Barclays Maintains an 'Overweight' on Splunk (SPLK); Growth Momentum Heading Into & Out of Q1
Tweet Send to a FriendGet Alerts SPLK Hot Sheet
Price: $46.70 +0.45%
Rating Summary:
12 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
12 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade SPLK Now!
Barclays maintains an 'Overweight' on Splunk (NASDAQ: SPLK) price target of $40.00.
Analyst, Raimo Lenschow, said, "Numbers were better than expected across the board...Guidance was modestly better than consensus, and we believe sets the company up for further 'beat & raise' quarters, especially given strong growth in both reported and deferred license revenue, the number of larger deals and aggressive sales force expansion. We continue to believe in the structural growth story with a potentially vast end-market opportunity."
For an analyst ratings summary and ratings history on Splunk click here. For more ratings news on Splunk click here.
Shares of Splunk closed at $32.56 yesterday, with a 52 week range of $28.49-$37.57.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Raimo Lenschow, said, "Numbers were better than expected across the board...Guidance was modestly better than consensus, and we believe sets the company up for further 'beat & raise' quarters, especially given strong growth in both reported and deferred license revenue, the number of larger deals and aggressive sales force expansion. We continue to believe in the structural growth story with a potentially vast end-market opportunity."
For an analyst ratings summary and ratings history on Splunk click here. For more ratings news on Splunk click here.
Shares of Splunk closed at $32.56 yesterday, with a 52 week range of $28.49-$37.57.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
